Letter Regarding Research Update: Phase 2

July 11, 2020

Dear Colleagues:

In our last communication from June 3, 2020, we provided guidance for operating in Phase 1: Limited Presence Phase to conduct your research safely. Interim President Bruce Jarrell has now authorized the University of Maryland, Baltimore (UMB) to move to Phase 2, the Ramping Up Phase, on Monday, July 27.

Phase 2 pertains to preclinical laboratory-based research and includes the following strict requirements for occupancy: no more than 50 percent occupancy of laboratories and research spaces with a minimum of 150 square feet per person to maintain physical distancing.

To conduct research under Phase 2, you must have completed all of the necessary steps outlined below. 
 
1. Register your personnel not already in the mandatory SAFE on Campus REDCap monitoring system using the instructions here.
 
2. Ensure new personnel successfully complete the UMB Office of Environmental Health and Safety (EHS) Mandatory Training Module here.
 
3. Read the EHS' COVID-19 Research Safety Plan here.
 
Responsibility for implementing and monitoring these steps rests with your chair/director. Please turn to them for further guidance.
 
We emphasize that the success of this program depends on compliance by all of us, on the self-monitoring of our health and exposure risks, and on the candid attestation of our health status.
 
Please follow all signage and instructions as they are critical for your health and the health of your employees and our community. Our ability to return to more normal research activities depends on our adherence to these steps and our ability to prevent a COVID-19 outbreak on campus.
 
Parking and Transportation Services will monitor garage occupancy levels daily and re-open additional facilities as needed. Please contact parkingcashier@umaryland.edu with questions or concerns.
 
 
Sincerely,
 
Laurie E. Locascio, PhD
Vice President for Research, University of Maryland
Chair, UMB Research Advisory Task Force
 
Margaret M. McCarthy, PhD
Professor and Chair, Department of Pharmacology, University of Maryland School of Medicine 
Deputy Chair, UMB Research Advisory Task Force